Long-term follow-up sustained monomorphic ventricular tachycardia Causes pump failure empiric antiarrhythmic therapy survival actuarial cardiac mortality rate consecutive patients sustained monomorphic ventricular tachycardia Patients groups group patients coronary disease group II patients nonischemic ventricular disease group III patients right ventricular disease group IV patients detectable heart disease Patients prospective schema class drugs case recurrence ventricular tachycardia amiodarone beta-blockers case recurrence ventricular tachycardia drug combinations surgery mean follow-up duration months first occurrence ventricular tachycardia clinical outcome patients years actuarial mortality rates groups II groups III IV mortality rate group group II groups II actuarial mortality rate ventricular ejection fraction Comparisons treatments difference actuarial mortality rates patients ventricular tachycardia ventricular ejection fraction 